Issa, Issa
Skov, Jakob
Falhammar, Henrik
Calissendorff, Jan
Lindh, Jonatan D.
Mannheimer, Buster
Funding for this research was provided by:
County Council of Värmland (930575)
Magnus Bergvall Foundation (2021-04226)
Stockholm County Medical Committee (HSTV18048)
clinical trial investigating for the development of diabetic neuropathy (CBX129801-DN-201)
Karolinska Institute
Article History
Received: 11 March 2022
Accepted: 8 November 2022
First Online: 15 November 2022
Declarations
:
: The authors declare no competing interests.
: The study was approved by the Regional Ethical Review Board (approval number 2015/2270–31/2) in Stockholm, Sweden.
: Due to the retrospective population-based design of this work, that only included de-identified individuals, informed consent to participate was waived.
: Due to the retrospective population-based design of this work, that only included de-identified individuals, informed consent to appear in the subsequent publication was waived.
: The authors declare no competing interests.